Break Through the Barriers of Traditional Cytogenetics with GPM
For decades, cytogenetic analysis has relied on karyotyping, FISH, and CMA—essential tools, but ones constrained by limited resolution, complex workflows, and incomplete results. Powered by Genomic Proximity Mapping™ (GPM), the CytoTerra® Cytogenetics Platform offers a transformative leap forward: a single, NGS-based assay that delivers comprehensive, genome-wide detection of chromosomal abnormalities—with greater clarity, speed, and ease than traditional methods combined. Unlock deeper insights, streamline your workflow, and move cytogenetics into the next generation with CytoTerra.
Less Time. More Insights. One Assay.
Our proprietary library preparation method, combined with standard short-read sequencing, is used to map and measure the spatial relationship between any two loci across the full complement of chromosomes in a cell. Advanced computational tools extract this sequential information to detect genetic variation and characterize all major types of chromosomal abnormalities.
The CytoTerra® Cytogenetics Platform
GPM Technology
Diverse Research Applications
Understanding the structure of our chromosomes is essential for the diagnosis and management of many diseases. Numerical chromosomal abnormalities (aneuploidies), structural rearrangements, and chromosomal damage cause inherited diseases—such as Down, Klinefelter, or Turner Syndrome (which affect 0.4 to 0.9% of newborns1)—and are associated with cancers such as leukemias and lymphomas.2 Despite the importance of chromosomal abnormalities in health and disease, traditional cytogenetics relies on a cascade of cumbersome methods which often fall short in identifying underlying aberrations.